GB1454109A - Medicament preparations - Google Patents
Medicament preparationsInfo
- Publication number
- GB1454109A GB1454109A GB5639473A GB5639473A GB1454109A GB 1454109 A GB1454109 A GB 1454109A GB 5639473 A GB5639473 A GB 5639473A GB 5639473 A GB5639473 A GB 5639473A GB 1454109 A GB1454109 A GB 1454109A
- Authority
- GB
- United Kingdom
- Prior art keywords
- medicament
- composition
- glycol
- dialkylated
- dione
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
1454109 Stabilised medicaments SYNTEX (USA) INC 5 Dec 1973 [8 Dec 1972 8 Nov 1973] 56394/73 Heading A5B Substantially anhydrous medicament compositions comprise a major amount (i.e. more than 50 % by weight of the composition, excluding the medicament) of a dialkylated mono- or polyalkylene glycol e.g. glyme, diglyme, triglyme, tetraglyme, dimethyl ether of triethylene glycol, polyethylene glycol 350, 550 and 750-dimethyl ethers, and a pharmaceutically effective amount of an active medicament or a pharmaceutically acceptable salt thereof, the composition being substantially devoid of peroxides and other oxidation products in quantities which interfere with the carrier or stabilizing properties of the composition, and containing up to 5% by weight of water, the dialkylated glycol serving to stabilize the chemical activity of the medicament. The composition may include at least one anti-oxidant for the dialkylated glycol e.g. propyl gallate, vitamin E, butylated hydroxyanisole, and/or butylated hydroxytoluene. The medicament may be an antibiotic such as tetracycline, oxytetracycline, chlorotetracycline, chloramphenicol, gramicidin, candicidin, and nystatin; an anaesthetic such as benzocaine and xylocaine: an analgesic such as aspirin and 2-(6-methoxy-2-naphthyl)propionic acid, antiinflammatory steroids such as 6α, 9α-difluoro- 11# - hydroxy - 16α, 17α-isopropylidenedioxypregna-1, 4-diene-3, 20-dione, 9α, 11#, 21-trichloro-6α-fluo-16α, 17α-isopropylidenedioxy-pregna-1, 4-diene-3, 20-dione; naturally occuring or synthetic prostaglandins such as PGE 2 and PGF 2 α; palmitic acid diethanolamide, oleic acid diethanolamide, antihistamines; antibaoterials and fungicides. The compositions may be in the form of creams, ointments, oral or vaginal tablets, rectal or vaginal suppositories, encapsulated preparations, bougies and food premixes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US00313431A US3833725A (en) | 1972-12-08 | 1972-12-08 | Dialkylated glycol compositions and medicament preparations containing same |
US41396573A | 1973-11-08 | 1973-11-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1454109A true GB1454109A (en) | 1976-10-27 |
Family
ID=26978866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB5639473A Expired GB1454109A (en) | 1972-12-08 | 1973-12-05 | Medicament preparations |
Country Status (6)
Country | Link |
---|---|
JP (1) | JPS5726244B2 (en) |
CA (1) | CA1043259A (en) |
DE (1) | DE2358644C3 (en) |
ES (1) | ES421299A1 (en) |
FR (1) | FR2209544B1 (en) |
GB (1) | GB1454109A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2563429C2 (en) * | 2009-07-09 | 2015-09-20 | Кордис Корпорейшн | Rapamicin-releasing stent |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5391110A (en) * | 1977-01-20 | 1978-08-10 | Yamanouchi Pharmaceut Co Ltd | Novel drug composition for rectal infusion |
US4115563A (en) * | 1977-03-14 | 1978-09-19 | Sterling Drug Inc. | Pharmaceutical steroid formulation |
US4310543A (en) * | 1980-10-09 | 1982-01-12 | Hoffmann-La Roche Inc. | Prostaglandin compositions |
AU546872B2 (en) * | 1982-06-16 | 1985-09-26 | Unilever Plc | Skin treatment compositions containing a fatty acid or ester |
GB8718886D0 (en) * | 1987-08-10 | 1987-09-16 | Ici America Inc | Composition |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1296515A (en) * | 1958-12-05 | 1962-06-22 | Boehringer & Soehne Gmbh | Process for making solutions of chloramphenicol in aqueous liquids |
US3308217A (en) * | 1965-02-09 | 1967-03-07 | Lowy Lawrence | Method of granulating materials for subsequent forming into tablets |
-
1973
- 1973-11-21 CA CA186,345A patent/CA1043259A/en not_active Expired
- 1973-11-24 DE DE19732358644 patent/DE2358644C3/en not_active Expired
- 1973-12-05 GB GB5639473A patent/GB1454109A/en not_active Expired
- 1973-12-07 JP JP13724373A patent/JPS5726244B2/ja not_active Expired
- 1973-12-07 ES ES421299A patent/ES421299A1/en not_active Expired
- 1973-12-07 FR FR7343805A patent/FR2209544B1/fr not_active Expired
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2563429C2 (en) * | 2009-07-09 | 2015-09-20 | Кордис Корпорейшн | Rapamicin-releasing stent |
US9327060B2 (en) | 2009-07-09 | 2016-05-03 | CARDINAL HEALTH SWITZERLAND 515 GmbH | Rapamycin reservoir eluting stent |
Also Published As
Publication number | Publication date |
---|---|
ES421299A1 (en) | 1977-05-16 |
JPS5726244B2 (en) | 1982-06-03 |
FR2209544A1 (en) | 1974-07-05 |
JPS5052220A (en) | 1975-05-09 |
AU6319173A (en) | 1975-06-05 |
FR2209544B1 (en) | 1978-03-24 |
DE2358644B2 (en) | 1979-04-05 |
DE2358644A1 (en) | 1974-07-04 |
DE2358644C3 (en) | 1979-11-15 |
CA1043259A (en) | 1978-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4011313A (en) | Medicament preparations | |
KR101089049B1 (en) | Formulations of lipophilic drugs | |
IE42692B1 (en) | Oestrogenic compositions for oral administration | |
US4310543A (en) | Prostaglandin compositions | |
NZ233415A (en) | Pharmaceutical foam for rectal administration of 5-aminosalicylic acid; dispenser | |
ZA200005915B (en) | Pharmaceutical compositions capable of being gelled. | |
HU176743B (en) | Process for preparing combined preparations with anabolic activity for oral application | |
FI945452A (en) | Effervescent medicinal product containing ibuprofen and method of manufacture | |
GB1454109A (en) | Medicament preparations | |
IL37026A (en) | Pharmaceutical preparations containing vitamin a derivatives | |
IE42950L (en) | X-ray contrast preparations | |
GB1279214A (en) | Long-acting oral carrier | |
US3833725A (en) | Dialkylated glycol compositions and medicament preparations containing same | |
ES477217A1 (en) | Sterol liposomes containing medicaments | |
ES8400028A1 (en) | Waterless thixotropic composition. | |
GB1285371A (en) | Improvements in or relating to therapeutic methods using prostaglandins | |
GB1457546A (en) | Pharmaceutical preparations comprising cephalosporin derivatives | |
IL79710A0 (en) | Substituted benzoate esters of estrogens,their preparation and pharmaceutical compositions containing them | |
GB1326528A (en) | Method of contraception and compositions used therein | |
JPS5750914A (en) | Betamethasone external pharmaceutical | |
DE2963545D1 (en) | Pharmaceutical composition containing all-e- or 13-z-7,8-dehydro-retinoic acid and process for its preparation | |
JPS57158719A (en) | Rectal administration pharmaceutical | |
GB1327560A (en) | Effervescent pharmaceutical preparations | |
JPS5735509A (en) | Analgesic and antiphlogistic cream | |
JPS5665819A (en) | Composition for mefenamic acid pharmaceutical |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |